The University of Chicago Header Logo

Connection

Randall Barnes to Humans

This is a "connection" page, showing publications Randall Barnes has written about Humans.
Connection Strength

0.139
  1. Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable? Am J Obstet Gynecol. 2014 Nov; 211(5):494.e1-5.
    View in: PubMed
    Score: 0.016
  2. The diagnosis and management of hirsutism. Semin Reprod Med. 2003 Aug; 21(3):285-93.
    View in: PubMed
    Score: 0.008
  3. The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum Reprod. 2002 Jan; 17(1):88-91.
    View in: PubMed
    Score: 0.007
  4. Breast cancer and HRT--what are the data? Int J Fertil Womens Med. 2001 Mar-Apr; 46(2):73-8.
    View in: PubMed
    Score: 0.007
  5. Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism. J Pediatr Endocrinol Metab. 2000; 13 Suppl 5:1285-9.
    View in: PubMed
    Score: 0.006
  6. The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies. J Endocrinol Invest. 1998 Oct; 21(9):567-79.
    View in: PubMed
    Score: 0.006
  7. Long-term suppression of testosterone after treatment with a gonadotropin-releasing hormone agonist in a woman with a presumed testosterone secreting ovarian tumor. J Clin Endocrinol Metab. 1997 Jun; 82(6):1746-8.
    View in: PubMed
    Score: 0.005
  8. Diagnosis and therapy of hyperandrogenism. Baillieres Clin Obstet Gynaecol. 1997 Jun; 11(2):369-96.
    View in: PubMed
    Score: 0.005
  9. Pathophysiology of ovarian steroid secretion in polycystic ovary syndrome. Semin Reprod Endocrinol. 1997 May; 15(2):159-68.
    View in: PubMed
    Score: 0.005
  10. Polycystic ovarian disease. Curr Ther Endocrinol Metab. 1997; 6:256-9.
    View in: PubMed
    Score: 0.005
  11. Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center study. J Clin Endocrinol Metab. 1996 Sep; 81(9):3408-11.
    View in: PubMed
    Score: 0.005
  12. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab. 1994 Nov; 79(5):1328-33.
    View in: PubMed
    Score: 0.004
  13. Menstrual disorders in adolescence. Endocrinol Metab Clin North Am. 1993 Sep; 22(3):491-505.
    View in: PubMed
    Score: 0.004
  14. Knowledge of obesity and its impact on reproductive health outcomes among urban women. J Community Health. 2013 Apr; 38(2):261-7.
    View in: PubMed
    Score: 0.004
  15. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1993 Feb; 76(2):450-5.
    View in: PubMed
    Score: 0.004
  16. Increased risk for polycystic ovary syndrome associated with human leukocyte antigen DQA1*0501. Am J Obstet Gynecol. 1992 Dec; 167(6):1803-6.
    View in: PubMed
    Score: 0.004
  17. Infertility patients' knowledge of the effects of obesity on reproductive health outcomes. Am J Obstet Gynecol. 2012 Dec; 207(6):509.e1-509.e10.
    View in: PubMed
    Score: 0.004
  18. Adrenal dysfunction and hirsutism. Clin Obstet Gynecol. 1991 Dec; 34(4):827-34.
    View in: PubMed
    Score: 0.003
  19. Bronchospasm after intramuscular 15-methyl prostaglandin F2 alpha and endotracheal intubation in a nonasthmatic patient. Anesth Analg. 1991 Jul; 73(1):87-9.
    View in: PubMed
    Score: 0.003
  20. Randomized controlled trial: effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization. Fertil Steril. 2011 Feb; 95(2):583-7.
    View in: PubMed
    Score: 0.003
  21. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989 Mar 02; 320(9):559-65.
    View in: PubMed
    Score: 0.003
  22. The polycystic ovary syndrome: pathogenesis and treatment. Ann Intern Med. 1989 Mar 01; 110(5):386-99.
    View in: PubMed
    Score: 0.003
  23. Characterization of functionally typical and atypical types of polycystic ovary syndrome. J Clin Endocrinol Metab. 2009 May; 94(5):1587-94.
    View in: PubMed
    Score: 0.003
  24. Studies of gene expression in human cumulus cells indicate pentraxin 3 as a possible marker for oocyte quality. Fertil Steril. 2005 Apr; 83 Suppl 1:1169-79.
    View in: PubMed
    Score: 0.002
  25. Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2005 Feb; 83(2):336-40.
    View in: PubMed
    Score: 0.002
  26. Delay of embryo transfer to day 5 results in decreased initial serum beta-human chorionic gonadotropin levels. Fertil Steril. 2003 Dec; 80(6):1359-63.
    View in: PubMed
    Score: 0.002
  27. Relationship between peak serum estradiol levels and treatment outcome in in vitro fertilization cycles after embryo transfer on day 3 or day 5. Fertil Steril. 2003 Jul; 80(1):75-9.
    View in: PubMed
    Score: 0.002
  28. Identification of seminiferous tubule aberrations and a low incidence of testicular microliths associated with the development of azoospermia. Fertil Steril. 1999 Sep; 72(3):467-71.
    View in: PubMed
    Score: 0.001
  29. Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet. 1999 Jul 31; 354(9176):365-9.
    View in: PubMed
    Score: 0.001
  30. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999 Jan; 22(1):141-6.
    View in: PubMed
    Score: 0.001
  31. Transmission disequilibrium of maternally-inherited CTLA-4 microsatellite alleles in idiopathic recurrent miscarriage. J Reprod Immunol. 1998 Nov; 40(2):147-57.
    View in: PubMed
    Score: 0.001
  32. A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism. Hum Reprod. 1997 Jul; 12(7):1416-20.
    View in: PubMed
    Score: 0.001
  33. Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor--a clinical research center study. J Clin Endocrinol Metab. 1996 Oct; 81(10):3802-6.
    View in: PubMed
    Score: 0.001
  34. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev. 1995 Jun; 16(3):322-53.
    View in: PubMed
    Score: 0.001
  35. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1994 Dec; 79(6):1686-92.
    View in: PubMed
    Score: 0.001
  36. Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism. Ann N Y Acad Sci. 1993 May 28; 687:162-81.
    View in: PubMed
    Score: 0.001
  37. Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1993 May; 76(5):1241-7.
    View in: PubMed
    Score: 0.001
  38. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992 Jul 16; 327(3):157-62.
    View in: PubMed
    Score: 0.001
  39. Transvaginal intratubal insemination by tactile sensation: a preliminary report. Fertil Steril. 1991 Nov; 56(5):984-6.
    View in: PubMed
    Score: 0.001
  40. Quantitative and qualitative tests for urinary luteinizing hormone. Comparison in spontaneous and clomiphene-citrate-treated cycles. J Reprod Med. 1990 Nov; 35(11):1051-4.
    View in: PubMed
    Score: 0.001
  41. Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil Steril. 1990 May; 53(5):785-91.
    View in: PubMed
    Score: 0.001
  42. Use of nafarelin for testing pituitary-ovarian function. J Reprod Med. 1989 Dec; 34(12 Suppl):1044-50.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.